(Q38477385)

3 September 2017

title

Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'. (English)

1 reference

3 September 2017

Tom P Freeman

1

1 reference

3 September 2017

Celia J A Morgan

2

1 reference

3 September 2017

James Vaughn-Jones

3

1 reference

3 September 2017

Nahida Hussain

4

1 reference

3 September 2017

Kash Karimi

5

1 reference

3 September 2017

H Valerie Curran

6

1 reference

3 September 2017

language of work or name

English

0 references

publication date

18 January 2012

1 reference

3 September 2017

1 reference

3 September 2017

volume

107

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

792-800

1 reference

What should be done about mephedrone?

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Instability of the ecstasy market and a new kid on the block: mephedrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Mephedrone: still available and twice the price

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Analyses of second-generation 'legal highs' in the UK: initial findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Mephedrone, new kid for the chop?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Mephedrone: use, subjective effects and health risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Dependence and psychosis with 4-methylmethcathinone (mephedrone) use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Drug addiction, dysregulation of reward, and allostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Inverted-U-shaped dopamine actions on human working memory and cognitive control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

A web-based survey on mephedrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Harms associated with psychoactive substances: findings of the UK National Drug Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

Mass‐information: mephedrone, myths, and the new generation of legal highs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2011.03719.X

10.1111/J.1360-0443.2011.03719.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference